Tumor ablation is an innovative treatment of tumors and cancerous cells. It is a minimally invasive mode of treatment wherein tissues are exposed to thermal energy till the point they reach cytotoxic levels, i.e. -400C or 600C. This technique is common in the treatment of liver, kidney, lung and bone. This method of treatment is designed for patients who haven’t had effective treatment conclusions in chemotherapy/radiotherapy or are not able to undergo surgical treatments.
Access Full Report at https://databridgemarketresearch.com/reports/global-tumour-ablation-market
Tumor ablation market is growing due to increasing prevalence of cancer patients and rising number of hospitals, surgical and ablation centers; the effects of these factors are mentioned below:
Expansion and strategic acquisitions utilized by the manufacturers:
The market is segmented on the basis of type as tumor ablation systems, image guidance products, accessories; cancer type is categorized into liver cancer, brain cancer, lung cancer, bone cancer, kidney cancer, pancreatic cancer, breast cancer, others; mode of treatment is segmented into surgical, laparoscopic, percutaneous; end users is categorized as hospitals, oncology clinics, others.
“According to Data Bridge Market Research, global tumor ablation market is expected to be growing at a substantial CAGR of 9.8% during the forecast period of 2017 to 2024”
Some of the major players operating in market are Medtronic, Boston Scientific Corporation, Abbott, Galil Medical Inc., Perseon Corporation, NeuWave Medical, Inc., Koninklijke Philips N.V., INTIO Inc., Mermaid Medical A/S, SonaCare Medical, LLC, DFINE, Inc., Misonix, BVM Medical Limited, AngioDynamics, COMSOL Inc, EDAP TMS and HealthTronics, Inc.
The market is growing at a substantial rate because of the various awareness programs and informative initiatives presented by the governments, authorities, medical centers have improved the knowledge amongst the world regarding the availability of alternative methods of treatment for cancer, instead of chemotherapy/radiotherapy. The combined activities of these authorities have increased the rate at which these services are being provided to patients with increasing patients preferring this method over surgeries or chemotherapy.
Global Tumor Ablation Market – Industry Trends and Forecast to 2026